WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $12.20, but opened at $12.5899. WuXi Biologics (Cayman) shares last traded at $11.93, with a volume of 425 shares.
Analyst Ratings Changes
Separately, Zacks Research raised WuXi Biologics (Cayman) to a “hold” rating in a research report on Friday, August 28th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, WuXi Biologics (Cayman) has an average rating of “Hold”.
View Our Latest Analysis on WXXWY
WuXi Biologics (Cayman) Price Performance
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Read More
- Five stocks we like better than WuXi Biologics (Cayman)
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
